期刊文献+

温阳健脾汤对2型糖尿病患者胰岛β细胞功能及血糖控制的影响 被引量:21

Effect of Wenyang Jianpi Decoction on Function of Islet β-Cell and Blood Glucose Control in Patients with T2DM
下载PDF
导出
摘要 目的:探讨温阳健脾汤联合恩格列净对2型糖尿病(T2DM)患者胰岛β细胞功能及血糖控制的影响。方法:选取符合纳入标准的T2DM患者104例,以随机数表法分为治疗组(52例)和对照组(52例)。对照组予以恩格列净治疗,治疗组予以温阳健脾汤联合恩格列净治疗,均治疗12周。对比两组治疗前、治疗12周后血糖[糖化血红蛋白(HbA1c)、空腹血糖(FPG)、餐后2 h血糖(2 hPG)]、胰岛β细胞功能[空腹C肽(FCP)、餐后2 h C肽(2 hPCP)]、胰岛素抵抗指数(HOMA-IR)、空腹胰岛素(FINS)、体质量指数(BMI)水平,并对比两组不良反应发生率。结果:两组治疗前HbA1c、FPG、2 hPG、FCP、2 hPCP、HOMA-IR、FINS、BMI水平相比,差异无统计学意义(P均>0.05);两组治疗12周后HbA1c、FPG、2hPG、HOMA-IR、FINS、BMI水平均较治疗前降低(P<0.05),FCP、2 hPCP水平均较治疗前提高(P<0.05),且治疗组改善幅度大于对照组(P<0.01,P<0.05);治疗组不良反应发生率9.62%(5/52)与对照组11.54%(6/52)相比,差异无统计学意义(P>0.05)。结论:温阳健脾汤与恩格列净联合应用治疗2型糖尿病可改善胰岛β细胞功能,减轻胰岛素抵抗,提高血糖控制效果,降低体质量指数,且具有安全性。 Objective:To investigate the effects of Wenyang Jianpi Decoction combined with Jardiance on function of isletβ-cell and blood glucose control in patients with type 2 diabetes mellitus(T2DM).Methods:A total of 104 patients with T2DM were randomly divided into the study group(n=52)and the control group(n=52).The control group was treated with Jardiance;on which basis,and the study group was also treated with Wenyang Jianpi Decoction.The treatment lasted for 12 weeks.The blood glucose levels,including glycated hemoglobin(HbA1c),fasting blood glucose(FPG)and postprandial 2 h blood glucose(2h PG);the function of isletβcell,such as fasting C peptide(FCP)and postprandial 2 h C peptide(2h PCP);the insulin resistance index(HOMA-IR),fasting insulin(FINS)and body mass index(BMI);and the incidence of adverse reactions were compared between before the treatment and after 12 weeks of the treatment in the two groups.Results:There were no statistical differences in the levels of HbA1c,FPG,2h PG,FCP,2h PCP,HOMA-IR,FINS and BMI between the two groups before the treatment(P>0.05).After 12 weeks of the treatment,the levels of HbA1c,FPG,2 hPG,HOMA-IR,FINS and BMI were decreased,and the levels of FCP and 2h PCP were increased than those before the treatment in the two groups;of which the improvements in the study group were more significant(P<0.01,P<0.05).The incidence of adverse reactions was 9.62%(5/52)in the study group,and it was 11.54%(6/52)in the control group;there was no statistical difference between the two groups(P>0.05).Conclusion:Wenyang Jianpi Decoction combined with Jardiance can improve the function of isletβ-cell,reduce insulin resistance,improve glycemic control,and lower body mass index in the treatment of type 2 diabetes.
作者 孙俊波 赵璐 赵逸菲 许华 SUN Junbo;ZHAO Lu;ZHAO Yifei;XU Hua(Henan Province Hospital of TCM,The Second Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450002,China;The Third Affiliated Hospital of Chinese Medicine,Zhengzhou 450008,China;Henan University of Chinese Medicine,Zhengzhou 450046,China)
出处 《中医药信息》 2019年第6期116-119,共4页 Information on Traditional Chinese Medicine
基金 河南省科技攻关计划项目(No.162102310445)
关键词 2型糖尿病 温阳健脾汤 恩格列净 血糖控制 胰岛Β细胞功能 T2DM Wenyang Jianpi Decoction Jardiance Blood glucose control Function of isletβcell
  • 相关文献

参考文献9

二级参考文献51

  • 1吕霄,赵猛,凌宏威,李伟.西格列汀对糖尿病前期人群的干预效果[J].中国老年学杂志,2014,34(1):26-29. 被引量:27
  • 2Wright EM, Loo DD, Hirayama BA. Biology of human :odium glucose transporters. Physiol Rev, 2011,91 : 733-794.
  • 3Zambrowicz B, Freiman J,Brown PM, et al. LX4211 ,adual SOLT1/ SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther, 2012,92 : 158-169.
  • 4Hediger MA, Rhoads DB. Molecular physiology of sodium-glu- cose cotransporters. Physiol Rev, 1994,74 : 993-1026.
  • 5Chao EC, Henry RR. SGLT2 inhibition-a novel strategy for dia- betes treatment. Nat Rev Drug Discov, 2010,9:551-559.
  • 6Washburn WN,Poucher SM. Different iating sodium-glucose co-trans- porter-2 inhibitors in development for the treatment of type 2 di- abetes mellitus. Expert Opin .Investig Drugs, 2013,22 : 463-486.
  • 7Stenl6f K,Cefalu WT, Kim KA, et al. Efficacy and safety of canagli- flozin monotherapy in subjects with type 2 diabetes mellitus inade- quately controlled with diet and exercise. Diabetes Obes Metab, 2013,15:372-382.
  • 8Fujita Y, Inagaki N. Renal sodium glucose cotransporter 2 in- hibitors as a novel therapeutic approach to treatment of type 2 diabetes: clinical data and mechanism of action. J Diabetes In- vestig, 2014,5 : 265-275.
  • 9Poudel RR. Renal glucose handling in diabetes and sodium glu- cose cotransporter 2 inhibition. Indian J Endocrinol Metab, 2013,17:588-593.
  • 10Macdonald FR,PeeI JE,Jones HB,et al. The novel sodium glu- cose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats. Diabetes Obes Metab, 2010,12 : 1004-1012.

共引文献6862

同被引文献189

引证文献21

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部